The critical role of discoidin domain receptors in the regulation of anti‐tumor immune responses
International Journal of Cancer · 15.06.2026 · 158 (12) · 3080-3090
DOI: 10.1002/ijc.70398 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Cancer, online erschienen am 25.02.2026. Verfasst von Sixin Jiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Chinese Academy of Medical Sciences Research Unit of Oral…. Hauptthemen laut MEDLINE: Neoplasms, Discoidin Domain Receptors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 101 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Research Funding from West China School/Hospital of Stomatology Sichuan University, Postdoctoral Research Funding of Sichuan University.
Abstract (Originalsprache)
Discoidin domain receptors (DDRs) are nonintegrin collagen receptors which could be activated by various collagens. Overexpressed in numerous cancers, DDRs participate in tumorigenesis, tumor growth, dissemination, and metastasis. Immune checkpoint inhibitors (ICIs) have demonstrated low response rates in tumors such as head and neck cancer and pancreatic cancer, possibly due to the insufficient presence of effector T cells and the abundant collagen fibers in the tumor microenvironment. Recently, several studies indicate that DDRs account for ICIs resistance. For instance, DDR1 can prevent the anti‐tumor immune responses via mediating the rearrangement of collagen fibers, increasing the secretion of interleukin‐18 (IL‐18) as well as facilitating the formation of neutrophil extracellular traps (NETs). DDR2 may participate in the establishment of immunosuppressive tumor microenvironment by recruiting myeloid‐derived suppressor cells (MDSCs) and promoting the M2 polarization of macrophages. Notably, the interaction between collagens and immune cells also acts as a pivotal role in mediating tumor immune escape. Targeting DDRs and upstream regulators including collagen has been reported to significantly restore the antitumor immunity or inhibit tumor development, such as utilizing DDR1 inhibitors via AI screening from FDA‐approved therapeutics or natural products, and strategies for collagen synthesis inhibition or collagen degradation. However, the above approaches are largely limited to preclinical studies and still warrant further validation in clinical trials. Based on the current evidences, DDRs serve as promising targets for improving the efficacy of ICIs against cancers; more studies are anticipated to reveal unclarified mechanisms of DDRs in regulating anti‐tumor immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Chinese Academy of Medical Sciences Research Unit of Oral Carcinogenesis and Management, West China Hospital of Stomatology, Si…
- Changsha Stomatological Hospital, Changsha, China.
- Department of Pathology, West China Hospital, Sichuan University, Chengdu, China.
ORCID-Profile: Qianming Chen, Xiaobo Luo
Förderung
- National Natural Science Foundation of China
- Research Funding from West China School/Hospital of Stomatology Sichuan University
- Postdoctoral Research Funding of Sichuan University
- Research and Development Program, West China Hospital of Stomatology, Sichuan University
- Key Research Program of Sichuan Provincial Science and Technology Agency
- Youth Fund Projects of Sichuan Provincial Science and Technology Agency
- CAMS Innovation Fund for Medical Sciences
- funding for key research and development projects supported by the Science and Technology Department of Sichuan Province
Zitieren
APA
Jiang, S., Qiu, Y., Wang, Q., Liu, X., Zhang, Y., Feng, H., Chen, Q., Jiang, Y., & Luo, X. (2026). The critical role of discoidin domain receptors in the regulation of anti‐tumor immune responses. International Journal of Cancer, 158(12), 3080-3090. https://doi.org/10.1002/ijc.70398
Vancouver
Jiang S, Qiu Y, Wang Q, Liu X, Zhang Y, Feng H, et al. The critical role of discoidin domain receptors in the regulation of anti‐tumor immune responses. International Journal of Cancer. 2026;158(12):3080-3090. doi:10.1002/ijc.70398
BibTeX
@article{Jiang2026,
author = {Jiang, Sixin and Qiu, Yan and Wang, Qiuhao and Liu, Xiangfei and Zhang, Yidi and Feng, Haifen and Chen, Qianming and Jiang, Yuchen and Luo, Xiaobo},
title = {The critical role of discoidin domain receptors in the regulation of anti‐tumor immune responses},
journal = {International Journal of Cancer},
year = {2026},
volume = {158},
number = {12},
pages = {3080--3090},
doi = {10.1002/ijc.70398}
}
EUVIMED